Stocks Health care QTEX
NASDAQ · Health careQTREX Quantum Ltd. (QTEX)
QTREX Quantum Ltd. reported revenue of $289K in fiscal 2025. It posted a net loss of $13.2M. In fiscal 2025 capital spending exceeded operating cash flow by $10M. At December 31, 2025 it held $3.2M in cash.
What QTREX Quantum Ltd. does
QTREX Quantum Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker QTEX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $289K | -$13.2M | -$0.45 | -$10M |
| 2024 | $0 | -$11.1M | -$0.60 | -$9.5M |
| 2023 | $0 | -$11.3M | -$0.93 | -$9.9M |
| 2022 | n/a | -$15M | -$1.39 | -$9.5M |
| 2021 | n/a | -$17.2M | -$3.24 | -$6.9M |
| 2021 | n/a | $16.9M | -$3.67 | -$1.9M |
Latest SEC filings
What QTREX Quantum Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 24, 2026
- September 2, 2026
- August 28, 2026
- August 27, 2026Passive stake (5% or more) SCHEDULE 13G
- August 21, 2026
- August 20, 2026
- August 19, 2026
- August 3, 2026
- July 27, 2026
- July 24, 2026
Questions about QTEX
What does QTREX Quantum Ltd. do?
QTREX Quantum Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker QTEX.
Is QTREX Quantum Ltd. profitable?
No. In fiscal 2025 it reported a net loss of $13.2M on revenue of $289K.
How much revenue does QTREX Quantum Ltd. make?
In fiscal 2025 QTREX Quantum Ltd. reported revenue of $289K.
When did QTREX Quantum Ltd. last report?
Its newest filing of any kind is the foreign issuer update from September 24, 2026.
Similar companies
Follow QTEX
Get an email when QTREX Quantum Ltd. files with the SEC: results, executive changes, material agreements and annual reports.
Follow QTEX: get an email when it filesWhere the numbers come from
Financial figures are the values QTREX Quantum Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.